SCHEMBL29598166

SCHEMBL29598166

COC(=O)c1cncc(-c2ccccc2)c1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
HPGD P15428 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
GAA P10253 2/20 0.48
MAPT P10636 2/20 0.48
LMNA P02545 1/20 0.48
PRKCZ Q05513 1/20 0.48
CFTR P13569 2/20 0.47
HSD17B10 Q99714 2/20 0.47
GABRA1 P14867 2/20 0.47
GABRG2 P18507 2/20 0.47
GABRB3 P28472 2/20 0.47
GABRA3 P34903 2/20 0.47
GABRA5 P31644 1/20 0.47
KDM4E B2RXH2 3/20 0.46
GLA P06280 1/20 0.46
FGFR1 P11362 1/20 0.46
SRC P12931 1/20 0.46
FGFR2 P21802 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24499499 1.00 ALDH1A1 (0.48) ALDH1A1HPGDMEN1KMT2AGAA
SCHEMBL24499494 0.83 PDCD1 (0.50) ALDH1A1HPGDMEN1KMT2AGAA
SCHEMBL4505316 0.80 ALDH1A1 (0.56) ALDH1A1HPGDMEN1KMT2AGAA
SCHEMBL368306 0.80 IKBKB (0.49) FGFR1FGFR3MAPK1IKBKBCHUK
SCHEMBL30205037 0.79 LMNA (0.49) ALDH1A1HPGDMEN1KMT2AGAA
SCHEMBL6927417 0.78 FGFR1 (0.58) ALDH1A1KMT2AGAALMNACFTR
SCHEMBL15975999 0.75 SLC6A3 (0.52) ALDH1A1HPGDMEN1KMT2AGAA
SCHEMBL21410018 0.75 ALDH1A1 (0.54) ALDH1A1HPGDMEN1KMT2AGAA
SCHEMBL25973455 0.74 TDO2 (0.48) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL2003190 0.74 KDM4E (0.50) ALDH1A1HPGDGAAMAPTCFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4255902-A1 2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER Orion Corporation (FI) 2023-10-11 EP disclosed
WO-2022117920-A1 2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER ORION CORPORATION (FI) 2022-06-09 WO disclosed